Diclofenac photodegradation with the Perovskites BaFe_yTi_1-yO₃ as catalysts

Perovskite oxides BaFe_yTi_1-yO₃, with y = 0, 0.6, 0.8 and 1, were prepared by ceramic (CM) and complex polymerization methods (CPM) and utilized in UV-LED (365 nm) photocatalytic degradation assays of 25 mg L^-1 diclofenac (DIC) model solutions. BaTiO₃-CM was also used in the photocatalytic degradation test of a real mineral water for human consumption spiked with 2 mg L^-1 DIC. The XRD patterns of the synthesized perovskites showed cubic structure for those prepared by CPM, with distortions of the cubic lattice to hexagonal or tetragonal when prepared by CM, except for BaTiO₃. All the perovskites showed good catalytic activity, higher than photolysis, except BaFeO₃-CM that presented similar results. BaTiO₃-CM and CPM and BaFeO₃-CPM were also utilized in UV-LED photocatalytic DIC degradation assays with peroxydisulfate addition. BaFeO₃-CPM and BaTiO₃-CPM showed better ability to persulfate activation, but the highest mineralization degree was obtained with BaTiO₃-CM. This last perovskite was also able to perform DIC degradation in a real matrix. The studied oxides show potentiality for photocatalytic degradation of organic compounds, with or without persulfate addition. A degradation mechanism is proposed.